Euclidean Capital’s Tenaya Therapeutics TNYA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $621K | Hold |
1,015,705
| – | – | 0.2% | 10 |
|
|
2025
Q1 | $579K | Hold |
1,015,705
| – | – | 0.22% | 10 |
|
|
2024
Q4 | $1.45M | Hold |
1,015,705
| – | – | 0.2% | 8 |
|
|
2024
Q3 | $1.96M | Hold |
1,015,705
| – | – | 0.22% | 9 |
|
|
2024
Q2 | $3.15M | Hold |
1,015,705
| – | – | 0.4% | 8 |
|
|
2024
Q1 | $5.31M | Hold |
1,015,705
| – | – | 0.68% | 9 |
|
|
2023
Q4 | $3.29M | Hold |
1,015,705
| – | – | 0.37% | 10 |
|
|
2023
Q3 | $2.59M | Buy |
1,015,705
+100,000
| +11% | +$255K | 0.57% | 10 |
|
|
2023
Q2 | $5.38M | Hold |
915,705
| – | – | 1.38% | 10 |
|
|
2023
Q1 | $2.61M | Hold |
915,705
| – | – | 2.29% | 9 |
|
|
2022
Q4 | $1.84M | Hold |
915,705
| – | – | 1.72% | 10 |
|
|
2022
Q3 | $2.66M | Hold |
915,705
| – | – | 2.47% | 8 |
|
|
2022
Q2 | $5.16M | Hold |
915,705
| – | – | 4.38% | 7 |
|
|
2022
Q1 | $10.8M | Hold |
915,705
| – | – | 6.27% | 6 |
|
|
2021
Q4 | $17.4M | Hold |
915,705
| – | – | 9.87% | 4 |
|
|
2021
Q3 | $18.9M | Buy |
+915,705
| New | +$18.9M | 9.19% | 4 |
|